$26m cash receipts is a record with a net profit of $3.8m is another record.
All metrics are scaling very fast indicating signficant traction and growth.
Expect another declaration of a special dividend in the next quarter or so of around 2c as the company is not requiring any further capital injection and is fully funded with a significant bank balance of ~$17m+
Whats not to like. Absolutely dominating and cannabilising the entire MedCan market as expected
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
